Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Vanda Pharmaceuticals (NQ: VNDA ) 4.660 +0.010 (+0.22%) Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Vanda Pharmaceuticals < Previous 1 2 3 4 5 Next > Over 200% Stock Upside - Vanda Pharmaceuticals Undervalued With Robust Portfolio And Pipeline: Analyst November 01, 2024 HC Wainwright initiates Buy on Vanda Pharmaceuticals with an $18 price target, citing undervaluation, a strong product portfolio, and growth in neurology. Via Benzinga Why Vanda Pharmaceuticals Stock Sank by Nearly 6% Today September 19, 2024 A regulator's decision drained the market's enthusiasm for the company. Via The Motley Fool FDA Strikes Off Vanda Pharmaceuticals' Tradipitant For Stomach Paralysis, Asks For Additional Studies September 19, 2024 The FDA rejected Vanda Pharmaceuticals' new drug application for tradipitant to treat gastroparesis, citing the need for more studies despite delays in its review process. Vanda argues the drug meets... Via Benzinga Exposures Product Safety Revolutionary Magnetic Therapy Could Speed Up Bipolar Treatment August 06, 2024 New research suggests that powerful magnets could effectively treat bipolar disorder. This therapy, which is known as accelerated intermittent theta burst stimulation (iTBS), uses magnetic waves... Via PressReach Exposures Product Safety Why Vanda Pharmaceuticals Stock Is Skyrocketing Today April 17, 2024 Future Pak wants Vanda, but Vanda doesn't want Future Pak. Via The Motley Fool What's Going On With Vanda Pharmaceuticals Shares Today? June 27, 2024 Vanda Pharmaceuticals shares decline as Future Pak withdraws acquisition offer following Vanda's rejection and lack of response. Via Benzinga Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session June 20, 2024 Via Benzinga Why Vuzix Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket June 20, 2024 Via Benzinga Vanda Pharmaceuticals And Other Big Stocks Moving Lower In Thursday's Pre-Market Session June 20, 2024 Via Benzinga Tesla, Nvidia, John Wiley & Sons And Other Big Stocks Moving Higher On Thursday June 13, 2024 Via Benzinga Glancy Prongay & Murray LLP Announces Investigation of Vanda Pharmaceuticals Inc. June 10, 2024 From Glancy Prongay & Murray LLP Via Business Wire S&P 500 Edges Lower; J. M. Smucker Shares Surge Following Earnings Beat June 06, 2024 Via Benzinga Topics Stocks Exposures US Equities Why G-III Apparel Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session June 06, 2024 Via Benzinga Crude Oil Jumps 2%; Lululemon Posts Upbeat Earnings June 06, 2024 Via Benzinga Exposures Fossil Fuels Vanda Pharmaceuticals Receives Another Takeover Proposal, Considers $466M Deal June 06, 2024 Cycle Pharmaceuticals wants to acquire Vanda Pharmaceuticals for $8 per share, or $466 million. Cycle focuses on rare neurological conditions. Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday June 06, 2024 Pre-market stock movers are worth checking out on Thursday morning as we dive into all of the hottest news affecting shares this morning! Via InvestorPlace Exact Sciences Reports Q1 Loss, Joins Beyond Meat, Duolingo And Other Big Stocks Moving Lower In Thursday's Pre-Market Session May 09, 2024 Via Benzinga VNDA Stock Earnings: Vanda Pharma Misses EPS, Misses Revenue for Q1 2024 May 08, 2024 VNDA stock results show that Vanda Pharma missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. Via InvestorPlace Shareholder Capital Delivers Letter to Independent Members of the Board of Vanda Pharmaceuticals April 25, 2024 From Shareholder Capital LLC Via GlobeNewswire US Supreme Court Declines To Hear Vanda Pharmaceuticals' Case Regarding Invalidation Of Patents For Its Sleep Disorder Drug, Hetlioz April 22, 2024 "Supreme Court denies review of Vanda Pharmaceuticals' patent revival attempt for Hetlioz sleep-disorder medication. Legal battle details, implications, and market impact." Via Benzinga Topics Intellectual Property Exposures Intellectual Property Crude Oil Dips 3%; U.S. Bancorp Profit Tops Views April 17, 2024 U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling more than 100 points on Wednesday. The Dow traded up 0.04% to 37,813.77 while the NASDAQ fell 0.78% to 15,742.21.... Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities 12 Health Care Stocks Moving In Wednesday's Intraday Session April 17, 2024 Via Benzinga Neuropsychiatric-Focused Vanda Pharmaceuticals Rejects Future Pak's Takeover Bid Valued Up To $7.75/Share April 17, 2024 Vanda Pharmaceuticals rebuffs unsolicited proposals from Future Pak LLC, citing undervaluation. Offers up to $7.75 per share. Board asserts resilient business with FDA-approved products. Future Pak... Via Benzinga Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session April 17, 2024 Shares of The Travelers Companies, Inc. (NYSE: TRV) fell sharply during Wednesday’s session following first-quarter earnings. Via Benzinga Why Is Trio Petroleum (TPET) Stock Down 22% Today? April 17, 2024 Trio Petroleum stock is falling on Wednesday as TPET investors learn of a securities purchase agreement and Senior Secured Note. Via InvestorPlace Why Is Trilogy Metals (TMQ) Stock Down 29% Today? April 17, 2024 Trilogy Metals stock is falling on Wednesday as TMQ investors react to reports that the government plans to block its Ambler Access Project. Via InvestorPlace Why Is Vanda Pharmaceuticals (VNDA) Stock Up 34% Today? April 17, 2024 Vanda Pharmaceuticals stock is heading higher on Wednesday as investors in VNDA learn of an acquisition offer for their shares. Via InvestorPlace 12 Health Care Stocks Moving In Wednesday's Pre-Market Session April 17, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday April 17, 2024 It's time to dive into the biggest pre-market stock movers with all of the hottest news worth reading about on Wednesday! Via InvestorPlace Nasdaq Gains 75 Points; Acuity Brands Posts Upbeat Earnings April 03, 2024 U.S. stocks traded higher toward the end of trading, with the S&P 500 gaining around 0.3% on Wednesday. The Dow traded up 0.08% to 39,200.08 while the NASDAQ rose 0.46% to 16,315.68. The S&P 500 also... Via Benzinga Topics Stocks Exposures US Equities < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
